In the previous paper of this series, 1) we reported the synthesis of the 12,13-seco norditerpenoid alkaloids from the norditerpenoid alkaloids. This is the key stage in the modification of the norditerpenoid alkaloids for evaluation of their biological activities. Herein, we have continued to describe in detail the further synthesis of the 12,13-seco norditerpenoid alkaloids.
Results and Discussion
In our investigation toward the modification of the bioactive norditerpenoid alkaloids, the synthesis of 12,13-seco norditerpenoid alkaloids is one of most difficult steps, which has not been reported in the literature before. After a series of unsuccessful experiments, 2, 3) we finally found that the 12,13-seco norditerpenoid alkaloids can be synthesized via a semipinacol rearrangement followed by reaction with Br 2 -HOAc. 1) This is the first novel access to the 12,13-seco norditerpenoid alkaloid recently reported by us.
To investigate further the effect of the A ring structures on the reaction, we have prepared a series of C-nor compounds (Chart 1), with different structural moieties of the A ring. The a,b-unsaturated ketone methyl sulfonate 4, C 25 H 37 NO 9 S (high resolution electron impact (HR-EI)-MS), was obtained using yunaconitine 1 4) as the starting material via 2 4) and 3 in three steps in nearly quantitative overall yields (Chart 2). The 1 H-and 13 C-NMR spectra of 4 indicated the presence of an a,b-unsaturated ketone moiety (d H 6.20, 6.37, each 1H, d, Jϭ10.2 Hz; d C 146.6 d, 132.0 d, 200.4 s) and a methylsulfonyl group (d H 3.11, 3H s; d C 38.5 q) which can be assigned at C-14 due to observation of the one-proton signal at d H 4.75 (d, Jϭ6.2 Hz) , attributable to H-14b. The reaction of 4 with NaOH was carried out in N,N-dimethylformamide (DMF) at 150°C for 6.5 h to give compounds 5 and 6 as a pair of epimers in 68% and 5% yield, respectively. Both compounds 5 and 6 have the same molecular formula C 24 H 33 NO 6 (HR-EI-MS). The 1 H-and 13 C-NMR spectra of 5 and 6 showed three aliphatic methoxyl groups (d H 3.26, 3.40, 3.48, each 3H, s; d C 58.2 q, 58.3 q, 59 .0 q for 5; d H 3.25, 3.34, 3.37, each 3H, s; d C 58.0 q, 58.4 q, 58 .9 q for 6), a carbonyl group (d C 211.6, s for 5; d C 212.1 s for 6) and an a,b-unsaturated ketone (d H 6.21, 6.26, each 1H, d, Jϭ10.0 Hz; d C 144.9 d, 132.4 d, 200 .6 s for 5; d H 6. 19, 6.26, each 1H, d, Jϭ10.0 Hz; d C 145.1 d, 132.2 d, 200 .8 s for 6). Their structures were determined on the basis of spectra compared, in particular, with compounds 9 1) and 10, 1) which were obtained from 8. 1) The d values of H-1 in the 1 H-NMR spectra of compounds 4, 5 and 6 displayed higher than the general cyclohexenone, possibly due to the presence of a steric hindrance between H-1 and H-12a in the these rigid molecules. Similarly, when compound 3 was subjected to treatment subsequently through reduction with H 2 /Pd-C, sulfonation and semipinacol rearrangement, another pair of the C-nor compounds 12 and 14 in 37% and 10% yield, respectively, were afforded (Chart 3). Both compounds 12 and 14 have the same molecular formula C 24 H 35 NO 6 (HR-EI-MS). Their 1 Hand 13 C-NMR spectra showed the absence of OMs group but two carbonyl groups (d H 216.9 s, 212.2 s for 12; d C 217.2 s, 212.7 s for 14). The structures of 12 and 14 were confirmed on the basis of comparison of the NMR spectra with those of the analogues such 5, 6, 9 and 10 (Table 1) . When the same reaction conditions were applied to 15 from the 3-ketone 13 by protection with ethylene glycol, 48% and 10% yields of compounds 16 and 17, respectively, were also obtained as a pair of epimers (Chart 4). Their structures were also confirmed by comparison of the NMR spectra with the analogues 5, 6, 9, 10, 12 and 14 (Table 1) . It should be noted that we have synthesized the C-nor compounds 5/6, 9/10, 12/14 and 16/17, as epimeric pairs at C-16, only in moderate yields (37-70%). It is apparent that this is possibly due to the vigorous reaction conditions (NaOH, high temperature). However, the attempt to enhance the yields of the resulting products using 8 in pyridine as the starting material at 140°C for 12 h resulted in the formation of the compounds 9 and 10 in poor yields (3%, 18%, respectively). This implies that the strong base, e.g., NaOH, is necessary for a semipinacol rearrangement. After a series of optimization for the reaction conditions, we have fortunately found that reactions of the compounds 4, 8, 13 and 15 with 8% NaOH carried out under the standard conditions in methanol at room temperature for 24 h gave the corresponding C-nor products 5, 9, 12 and 16, to an excellent extent, in 95%, 92%, 100% and 90% yield, respectively. Therefore, this successful optimization provided a good base for us to further synthesize the final 12,13-seco products via cleavage of the C(12)-C(14) bond of the C-nor compounds. In addition to the context of this discussion on the semipinacol rearrangement, it is of interest to note that only the major one of two spots on TLC of the resulting products before work-up were observed but finally obtaining the major products bearing the 16a-methoxyl groups, apparently by an epimerization process under the alkaline conditions from the 16b-OCH 3 group to the 16a-OCH 3 group. This is plausible for the C-nor compounds bearing the 16a-OCH 3 group without the de-stabilizing interaction between the 16-OCH 3 and the 8b-OH group.
Recently, we reported the preparation of the key intermediates 18, 19 and 20 using different eq of Br 2 in HOAc from 9 in 40%, 29% and 10% yield, respectively. 1) But, the results obtained in further study clearly indicated that cleavage of the C(12)-C(14) bond with aromatization of the D ring greatly depended on the structures of the substrates and the exact reaction conditions. Accordingly, as an important part of our continuing synthetic study of the 12,13-seco norditerpenoid alkaloids, we have further studied the role of the structures of the A ring in the cleavage of the C(12)-C(14) bond of the C-nor compounds. Treatment of the C-nor compound 5 with 1. (31) was converted to 30 upon treatment with Na 2 CO 3 (Chart 7). The results of the studies mentioned above indicated the following points: 1). the 1a-OCH 3 group of the C-nor molecules such as 9, 10 could participate in the cleavage reaction but was not in itself necessary; 2). the a,bunsaturated ketone or the 3-ketone of the A ring (e.g., 5 or 13, 14) also may enhance slightly the yields of the resulting products; 3). it is apparent that SOCl 2 in benzene instead of Br 2 in HOAc should be used in the cleavage C-nor compounds not bearing the 1-OCH 3 group.
The halogen-containing 12,13-seco norditerpenoid alkaloids such as 21, 24 and 26 were subjected to treatment with 5% KOH in ethanol under conditions (room temperature, or 50°C; 30 min or 2 h, respectively) resulting in elimination to produce the 12,13-seco compounds bearing the D 10(12) double bonds (25, 27) in nearly quantitative yields (Charts 5, 6).
It is worthy of note that our attempts to cleavage of the tetrahydrofuran ring of 33 using a variety of reagents (e.g., SeO 2 , H 2 /Pd-C, HClO 4 or HBr) were not successful. Only compounds 30 and 34 were obtained by reaction of 33 with 40% HBr in CH 2 Cl 2 at room temperature for 2 h and 80°C for 3 h, respectively (Chart 7). The molecular formula of both analogues 30 (C 26 H 35 NO 7 ) and 34 (C 23 H 31 NO 6 ) was determined by their HR-EI-MS. The structures of 30 an 34 were determined by comparison of the NMR spectra with the known compound 33. 1) In summary, we have continued to investigate further the nature of the stereoselectivity of the key cleavage reactions of C(12)-C(13) bonds and to develop practical protocols for this purpose. Meanwhile, a series of new norditerpenoid alkaloids were obtained. This is very useful for studies of the chemistry of this class of alkaloids.
Experimental
General Experimental Procedures Melting points are uncorrected. Optical rotations were measured with a JASCO DIP-370 polarimeter at 20Ϯ1°C.
1 H-and 13 C-NMR spectra were measured on a Bruker AC-E 200 or a Varian INOVA-400/54 spectrometer, in CDCl 3 with tetramethylsilane (TMS) as internal standard; IR spectra were recorded on a Perkin-Elmer 983 spectrometer; MS were obtained with a VG Auto spec-3000 mass spectrometer; TLC was performed on silica gel GF 254 percolated plates, sprayed with a modified Dragendoff 's reagent for detection; Column chromatography was carried out on Silica gel H (10-40 mm); All silica gel GF 254 and silica gel H used in the experiments were purchased from the Qingdao Sea Chemical.
Compound 2 To a solution of yunaconitine 1 (1066 mg, 1.62 mmol) in acetone (20 ml), Jone's reagent (1.75 ml, 4.85 mmol) was added dropwise under ice bath. After this, the solution was stirred for 20 min. Deluting (H 2 O, 20 ml), basifying (NH 4 OH, pHϭ11), extraction (CHCl 3 , 20 mlϫ5), drying (Na 2 SO 4 ) afforded the product as colorless needle crystals, 1063 mg (100% Compound 3 A solution of 3-dehydroyunaconitine (2) (1063 mg, 1.62 mmol) in 5% methanolic NaOH (25 ml) was heated at 55°C for 30 min. Removal of solvent, deluting (H 2 O, 10 ml), extraction (CHCl 3 , 10 mlϫ5), drying (Na 2 SO 4 ) and evaporation afforded the product as white amorphous powder, 726 mg (100% Compounds 5 and 6 Method A: To a solution of compund 4 (526 mg, 1.0 mmol) in DMF (30 ml), NaOH (100 mg) was added and the solution was heated at 150°C for 6.5 h. Removal of solvent, deluting (H 2 O), extraction (CHCl 3 , 25 mlϫ3), drying (Na 2 SO 4 ), evaporation and column chromatography (silica gel H, cyclohexane/acetoneϭ3 : 1) afforded the pure products as white amorphous powder, 5 (290 mg, 68%) and 6 (20 mg, 5%).
Method B: A mixture of compound 4 (100 mg, 0.19 mmol) in 8% methanolic NaOH (5 ml) was stirred at room temperature for 24 h. Removal of solvent, deluting (H 2 O), extraction (CHCl 3 , 5 mlϫ4), drying (Na 2 SO 4 ) and evaporation afforded the product as white amorphous powder 5: 78 mg (95%); Rf 0.66 (cyclohexane/acetoneϭ1 : 1); [a] Compound 8 To a solution of pseudaconine (7) 5) (185 mg, 0.38 mmol) in pyridine (10 ml), MsCl (0.09 ml, 1.15 mmol) was added and the solution was stirred at room temperature for 2 h. Removal of solvent, basifying (10% Na 2 CO 3 ), extraction (CHCl 3 , 10 mlϫ3), drying (Na 2 SO 4 ), evaporation and column chromatography (silica gel H, cyclohexane/acetone/diethylamineϭ 4 : 2 : 0.1) afforded the product as white amorphous powder, 165 mg (78%); It was idenfied by comparison of TLC (silica gel G, Rf 0.31, cyclohexane/ acetoneϭ1 : 1) with the authentic sample.
Compounds 9 and 10 Method A: To a solution of Compound 8 (160 mg, 0.28 mmol) in DMF (8 ml), NaOH (30 mg) was added and the solution was heated at 150°C for 24 h. Removal of solvent, deluting (H 2 O, 8 ml), extraction (CHCl 3 , 8 mlϫ3), drying (Na 2 SO 4 ), evaporation and column chromatography (silica gel H, cyclohexane/acetoneϭ5 : 1) afforded the pure products as white amorphous powder, 9 (95 mg, 70%) and 10 (20 mg, 15%).
Method B: A solution of Compound 8 (470 mg, 0.84 mmol) in pyridine (20 ml) was refluxed at 140°C for 12 h. Removal of solvent and column chromatography (silica gel H, petroleum/acetoneϭ3 : 1) afforded the products (9: colorless needle crystals, 12 mg, 3%; 10: white amorphous powder, 71 mg, 18%. besides the starting material (250 mg).
Method C: A solution of 14-methylsulfonyl pseudaconine (10) (670 mg, 1.194 mmol) in 8% methanolic NaOH (35 ml) was stirred at room temperature for 12 h. Removal of solvent, deluting (H 2 O, 30 ml), extraction (CHCl 3 , 30 mlϫ3), drying (Na 2 SO 4 ), evaporation and column chromatography (silica gel H, petroleum/acetoneϭ3 : 1) afforded the product 9 as colorless needle crystals, 513 mg (92%) The structures of 9 and 10 were identified by comparison of TLC (cyclohexane/acetoneϭ7 : 3, Rf: 0.36 for 9; 0.63 for 10).
Compound 13 To a solution of Compound 11 (1.58 g, 3.50 mmol) in pyridine (50 ml), MsCl (0.55 ml, 7.10 mmol) was added and the solution was heated at 40°C for 1.5 h. Removal of solvent, basifying (10% Na 2 CO 3 ), extraction (CHCl 3 , 25 mlϫ3), drying (Na 2 SO 4 ) and evaporation in vacuum and crystallization (ether/acetone) afforded the pure product as colorless needle crystals, 1.86 g, (100%). mp 118.5-119°C; Rf 0.60 (cyclohexane/acetoneϭ 1 : 1); [a] Compounds 12 and 14 Method A: To a solution of compound 13 (213 mg, 0.40 mmol) in DMF (13 ml), NaOH (90 mg) was added and the solution was heated at 150°C for 12 h. Removal of solvent, deluting (H 2 O, 15 ml), extraction (CHCl 3 , 15 mlϫ3), drying (Na 2 SO 4 ), evaporation and column chromatography (silica gel H, petroleum/acetoneϭ3 : 1) afforded the products as white amorphous powder (12: 65 mg, 37%; 14: 18 mg, 10%).
Method B: A solution of compound 13 (85 mg, 0.16 mmol) in 8% methanolic NaOH (5 ml) was stirred at room temperature for 24 h. Removal of solvent, deluting (H 2 O, 5 ml), extraction (CHCl 3 , 5 mlϫ3), drying (Na 2 SO 4 ) and evaporation to dryness afforded the product as white amorphous powder (12: 70 mg, 100%), Rf 0.50 (cyclohexane/acetoneϭ1 : 1). 12: [a] Compound 15 To a solution of compound 12 (500 mg, 0.95 mmol) in anhydrous benzene (30 ml), a mixture of TsOH (200 mg) and glycol (3 ml) was added and the solution was refluxed for 5 h under dropwise addition of benzene (50 ml) using a water separator. Basifying (10% Na 2 CO 3 , pHϾ9), separating the water layer, extraction (CHCl 3 , 20 mlϫ2), drying (Na 2 SO 4 ) and removal of solvent afforded the product as white amorphous powder, 511 mg, (95%). Rf 0.57 (ether/acetoneϭ9 : 1); [a] Compounds 16 and 17 Method A: To a solution of compound 15 (780 mg, 1.36 mmol) in DMF (60 ml), NaOH (375 mg) was added and the solution was heated at 160°C for 15 h. Removal of solvent, deluting (H 2 O, 50 ml), extraction (CHCl 3 , 45 mlϫ3), drying (Na 2 SO 4 ), evaporation to dryness and column chromatography (silica gel H, ether/acetoneϭ95 : 5) Method B: A solution of compound 15 (90 mg, 0.16 mmol) in 8% methanolic NaOH (5 ml) was stirred at room temperature for 24 h. Removal of solvent, deluting (H 2 O, 5 ml), extraction (CHCl 3 , 5 mlϫ3), drying (Na 2 SO 4 ) and evaporation to dryness afforded the product 16 as white amorphous powder, 67 mg (90%).
Compounds 21, 22 and 23 To a solution of compound 5 (280 mg, 0.65 mmol) in glacial acetic acid (7 ml), Br 2 (0.035 ml, 0.69 mmol) was added dropwise and the solution was stirred at room temperature 4 h. Basifying (saturated Na 2 CO 3 , pHϾ9), extraction (CHCl 3 , 25 mlϫ3), drying (Na 2 SO 4 ), removal of solvent and column chromatography (silica gel H, cyclohexane/acetoneϭ3 : 1) afforded the pure products (21: white amorphous powder, 65 mg, 20%; 22ϩ23: white amorphous powder, 170 mg, 60% 4.15 (1H, dd, Jϭ11.7, 3.5 Hz, 6.42 (1H, d, Jϭ10.4 Hz, 6.64 (1H, s, 6.88 (1H, s, 7.25 (1H, d, Jϭ10.4 Hz, Compound 24 Method A: To a solution of compound 5 (35 mg, 0.08 mmol) in anhydrous benzene (2 ml), SOCl 2 (0.6 ml) was added and the solution was first stirred at room temperature overnight, to which then 10% Na 2 CO 3 (2 ml) was added and stirred continuously for 5 min. Extraction (CHCl 3 , 3 mlϫ3), drying (Na 2 SO 4 ), removal of solvent and column chromatography (silica gel H, cyclohexane/acetoneϭ3 : 1) afforded the products as white amorphous powder, 21 mg (71%).
Method B: To a solution of compound 6 (23 mg, 0.05 mmol) in anhydrous benzene (1 ml), SOCl 2 (0.4 ml) was added dropwise and the solution was stirred at room temperature overnight. Basifying (10% Na 2 CO 3 , pHϾ9), extraction (CHCl 3 , 3 mlϫ3), drying (Na 2 SO 4 ) and removal of solvent afforded the product as white amorphous powder, 25 mg (100%). Rf 0.73 (cyclohexane/acetoneϭ1 : 1); [a] Table 2 ; EI-MS m/z (%) 411 (M Compound 26 To a solution of compound 16 or compound 17 (100 mg, 0.21 mmol) in anhydrous benzene (5 ml), SOCl 2 (0.5 ml) was added dropwise and the solution was stirred at room temperature overnight. Removal of solvent, basifying (10% Na 2 CO 3 , pHϾ9), extraction (CHCl 3 , 5 mlϫ3), drying (Na 2 SO 4 ), evaporation and column chromatography (silica gel H, cyclohexane/acetoneϭ3 : 1) afforded the product as white amorphous powder, 30 mg (40%). Rf 0.83 (cyclohexane/acetoneϭ1 : 1); [a] Cl, 449.1969) .
Compund 27 A solution of compound 26 (45 mg, 0.1 mmol) in 5% ethanolic KOH (3 ml) was stirred at room temperature for 2 h overnight. Removal of solvent, deluting (H 2 O, 5 ml), extraction (CHCl 3 , 5 mlϫ3), drying (Na 2 SO 4 ) and evaporation to dryness afforded the product as white amorphous powder, 43 mg (100%). Rf 0.52 (cyclohexane/acetoneϭ7 : 3); [a] D 20 ϩ144.5°(cϭ1.01, CHCl 3 ); IR (KBr) cm
Ϫ1
: 3451 (OH), 2928 , 2845 , 1714 (CO), 1610 , 1502 , 1451 , 1351 , 1308 , 1246 , 1209 , 1109 Compound 28 To a solution of compound 10 (242 mg, 0.52 mmol) in pyridine (5 ml), Ac 2 O (1 ml) was added and the solution was stirred at room temperature for 2 h. Removal of solvent, basifying (10% Na 2 CO 3 , pHϾ9), extraction (CHCl 3 , 5 mlϫ3), drying (Na 2 SO 4 ) and evaporation afforded the product as white amorphous powder, 262 mg (100%). Rf 0.72 (cyclohexane/acetoneϭ7 : 3); [a] 
